HZNP — Horizon Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareBalancedLarge Cap
- $26.63bn
- $26.72bn
- $3.63bn
US STOCKS-Wall Street ends higher as investors await US inflation, jobs data
US STOCKS-Wall Street gains as investors eye upcoming economic data
U.S. STOCKS ON THE MOVE-Danaher, Goldman Sachs, Generac Holdings
U.S. STOCKS ON THE MOVE-3M, RPT Realty, CN Energy
Refinitiv Newscasts - Trading at Noon: Wall Street sent higher after Chinese intervention
U.S. STOCKS ON THE MOVE-Hawaiian Electric, Novocure, Boston Scientific
Horizon Therapeutics rises after US FTC pauses challenge to block Amgen deal
US FTC suspends challenge to block Amgen's $27.8 bln deal for Horizon Therapeutics (updated)
US FTC suspends challenge to Amgen's deal for Horizon Therapeutics
Amgen up after Horizon Therapeutics sees Tepezza sales rise
Horizon Therapeutics PLC reports results for the quarter ended in June - Earnings Summary
Brief: Horizon Therapeutics Q2 Adjusted EPS USD 1.2 Vs. IBES Estimate USD 1.03
Brief: Amgen Says On June 22, FTC Filed Administrative Complaint Alleging Co's Proposed Acquisition Of Horizon Would Violate Federal Antitrust Laws - SEC Filing
Street View: Amgen to face bumpy H2 as competitive headwinds persist
Horizon Therapeutics PLC expected to post earnings of $1.12 a share - Earnings Preview
Amgen quarterly revenue rises 6%, profit beats Street estimates (updated)
Amgen quarterly revenue rises 6%, profit beats Street estimates
PREVIEW: Amgen ticks up with earnings on deck
What to Watch in the Day Ahead - Thursday, Aug 3